Guidelines on asbestos-related pleuropulmonary disease;Normativa sobre el asbesto y sus enfermedades pleuropulmonares

Archivos de Bronconeumologia

Volumn 41, Issue 3, 2005, Pages 153-168

  Isidro Montes, I ^a,i   Abu Shams, K ^b   Alday, E ^c   Carretero Sastre, J L ^d   Ferrer Sancho, J ^e   Freixa Blanxart, A ^f   Monso Molas E ^g   Pascal Martinez I ^b   Rodriguez Becerra E ^h   Rodriguez Panadero F ^h  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Universidad Pública de Navarra   (Spain)

^c Inst Nac Seguridad Higiene el T   (Spain)

^d HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f Ctro Nac de Condiciones de Trabajo   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

ⁱ Instituto Nacional de Silicosis   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CHRYSOTILE; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 2;

ALGORITHM; ANAMNESIS; ASBESTOSIS; ATELECTASIS; BRONCHOSCOPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENVIRONMENTAL EXPOSURE; FORCED EXPIRATORY VOLUME; HISTOLOGY; HUMAN; INCIDENCE; LAW; LUNG DISEASE; LUNG FUNCTION; LUNG LAVAGE; OCCUPATIONAL EXPOSURE; PATIENT CARE; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

EID: 20144387527     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13071586     Document Type: Article

References (92)

1. BOE de 7 de noviembre de 1984. Reglamento sobre trabajos con riesgo por amianto. Artícule 2 de la Orden 31/10/84 del Ministerio de Trabajo y Seguridad Social.
2. Cvitanovic S, Znaor L, Konsa T, Ivancevic Z, Peric I, Erceg M, et al Z. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study. Croat Med J. 2003;44:618-25.
3. Rigarti C, Aldieri E, Bergandi L, Tomatis M, Fenoglio I, Costamagna C, et al. Long and short fiber amosite asbestos alters at a different extent the redox metabolism in human lung epithelial cells. Toxicol Appl Pharmacol. 2003;193:106-15.
4. Begin R, Cantin A, Mosse G. Recent advances in the pathogenesis and clinical assessment of mineral dust pneumoconiosis: asbestosis silicosis and coal pneumoconiosis. Eur Respir J. 1989;2:988.
5. Begin R, Dufresne A, Plante F, et al. Asbestos related disorders. Can Respir J. 1994;1:167.
6. Perkins RC, Scheule RK, Hamilton R, Gomes G, Freidman G, Holian A. Human alveolar macrophage cytokine release in response to in vitro and In vivo asbestos exposure. Exp Lung Res. 1993;19:55-65.
7. Rom WN, Travis WD, Brody AR. Celular an molecular basis of the asbestos-related diseases. Am Rev Respir Dis. 1991;143:408.
8. Nelson HN, Kelsey KT. The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene. 2002;21:7284-8.
9. Lohani M, Dopp E, Becker HH, Seth K, Schiffmann D, Rahman Q. Smoking enhances asbestos-induced genotoxicity, relative involvement of chromosome 1: a study using multicolour FISH with tandem labelling. Toxicol Lett. 2002;136:55-63.
10. Turner-Warwick M, Parkes WR. Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J. 1965;1:886.
11. Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol. 1999;180:167-72.
12. Murthy SS, Testa JR. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol. 1999;180:150-7.
13. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29:2-17.
14. Liddell FDK, McDonald JC. Radiological findings as predictors of mortality in Quebec asbestos workers. Br J Ind Med. 1980;37: 257-67.
15. McDonald JC, Liddell FD, Gibbs GW, Eyssen GE, McDonald AD. Dust exposure and mortality in chrysotile mining 1919-1975. Br J Ind Med. 1980;37:11-24.
16. Lilis R, Miller A, Godbold J, Chan E, Benkert S, Selikoff IJ. The effect of asbestos-induced pleural fibrosis on pulmonary function: quantitative evaluation. Ann N Y Acad Sci. 1991;643:162-8.
17. Kohyama N, Suzuki Y. Analysis of asbestos fibers in lung parenchyma, pleural plaques and mesothelioma tissues of North American insulation workers. Ann N Y Acad Sci. 1991;643:27-52.
18. Becklake MR, Case BW. Fiber burden and asbestos-related lung disease: determinants of dose-response relationships. Am J Respir Crit Care Med. 1994;150:1488-92.
19. Meredith SK, McDonald JC. Work-related respiratory disease in the United Kingdom, 1989-1992: report on the SWORD project. Occup Med (Lond). 1994;44:183-9.
20. Nicholson WJ. Comparative dose-response relationships of asbestos fiber types: magnitudes and uncertainties. Ann N Y Acad Sci. 1991;643:74-84.
21. Talcott J, Thurber W, Gaensler E, Antman K, Li FP. Mesothelioma in manufacturers of asbestos-containing cigarette filters. Lancet. 1987;1:392.
22. Wagner JC. The discovery of the association between blue asbestos and mesotheliomas and the aftermath. Br J Ind Med. 1991;48: 399-403.
23. Selikoff IJ, Seidman H. Asbestos-associated deaths among workers in the United States and Canada, 1967-1987. Ann N Y Acad Sci. 1991;643:1-14.
24. Nicholson WJ, Landrigan PJ. The carcinogenicity of chrysotile asbestos. Adv Med Environ Toxicol. 1994;22:407-23.
25. Smith AH, Wright CC. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med. 1996;30:252-66.
26. Badorrey MI, Monso E, Teixido A, Pifarré R, Rosell A, Llatjos M, et al. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 1996;86:179-86.
27. Badorrey MI, Monsó E, Teixidó A, Pifarré R, Rosell A, Llatjos M. Frecuencia y riesgo de neoplasia broncopulmonar relacionada con asbestos. Med Clin (Barc). 2001;117:1-6.
28. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historial context. Eur Respir J. 1996;9:1932-42.
29. Liddell FD, McDonald AD, McDonald JC. Dust exposure and lung cancer in Quebec chrysotile miners and millers. Ann Occup Hyg. 1998;42:7-20.
30. International Labour Office. Guidelines for the use of ILO international classification of radiographs of pneumoconioses. Revised edition International Labour Office Safety and Health series n.° 22 (Rev 80). Geneva: International Labour Office; 1980.
31. Murphy RL, Becklake MR, Brooks SM, et al. The diagnosis of non-malignant diseases related to asbestos. Am Rev Respir Dis. 1986;134:363-8.
32. Roach HD, Davies GJ, Attanoos R, Crane M, Adams H, Phillips S. Asbestos: when the dust settles an imaging review of asbestos-related disease. Radiographics. 2002;22:S167-S84.
33. Copley SJ, Wells AU, Sivakumaran P, Rubens MB, Lee YC, Desai SR, et al. Asbestosis and idiophatic pulmonary fibrosis: comparison of thin-section CT features. Radiology. 2003;229:731-6.
34. De Vuyst P, Gevenois PA. Asbestosis. En: Hendrick DJ, Sherwood P, Beckett WS, Churg A, editors. Occupational disorders of the lung. London: WB Saunders; 2002. p. 143-62.
35. Ross RM. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest. 2003;124:1120-8.
36. Murray KA, Gamsu G, Webb WR, Salmon CJ, Egger MJ. High-resolution computed tomography sampling for detection of asbestos-related lung disease. Acad Radiol. 1995;2:111-5.
37. a ed. Buenos Aires: Editorial Panamericana; 1999. p. 2403-31.
38. Gevenois PA, De Maertelaer V, Madani A, Winant C, Sergent G, De Vuyst P. Asbestosis, pleural plaques and diffuse pleural thickening: the distinct benign responses to asbestos exposure. Eur Respir J. 1998;11:1021-7.
39. Gamsu G, Salmon CJ, Warnock ML, Blanc PD. CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods. AJR Am J Roentgenol. 1995;164:63.
40. Bégin R, Samet JM, Shaikh RA, Harcher P, Schenkerm M, Balmes J, editors. Asbestos-related diseases. En: Harcher P, Schenkerm M, Balmes J, editors. Occupational and environmental respiratory disease. St. Louis: Mosby; 1996. p. 293-320.
41. Lee YC, Singh B, Pang SC, DE Klerk NH, Hillman DR, Musk AW. Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med. 2003;60:611.
42. Kane AB. Asbestos bodies: clues to the mechanism of asbestos toxicity? Hum Pathol. 2003;34:735-6.
43. World Health Organization. Guidelines for Air Quality. Geneva: WHO; 2000.
44. De Vuyst P, Karjalainen A, Dumortier P, Pairon JC, Monso E, Brochard P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. Eur Respir J. 1998;11:1416-26.
45. Smith MJ, Naylor B. A method for extracting ferrugionus bodies from sputum and pulmonary tissue. Am J Clin Pathol. 1972; 58:250-4.
46. Tossavainen A, Techn D. Exposure criteria for clinical diagnosis. Proceeding of International Expert Meeting on Asbestos, asbestosis and cancer Finnish Institute of Occupational Health. Helsinki; 1997.
47. Churg A. Nonneoplasic disease caused by asbestos. En: Churg A, Green FHY, editors. Pathology of occupational lung disease. Baltimore: Williams & Wilkins; 1998. p. 277-338.
48. Constantopoulos SH, Saratzis NA, Kontogiannis D, Karantanas A, Goudevenos JA, Katsiotis P. Tremolite whitewashing and pleural calcifications. Chest. 1987;92:709-12.
49. Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA. 1982;247:617-22.
50. Rudd R. Benign pleural disease. En: Hendrick DJ, editor. Occupational disorders of the lung. London: Saunders Ed.; 2002.
51. Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis. 1987;71:113-21.
52. Voisin C, Fisekci F, Voisin-Saltiel S, Ameille J, Brochard P, Pairon JC. Asbestos-related rounded atelectasis. Radiologic and mineralogic data in 23 cases. Chest. 1995;197:447-81.
53. American Thoracic Society. Medical Section of the American Lung Association: the diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis. 1986;134:363-8.
54. Burdorf A, Dahhan M, Swuste P. Occupational characteristics of cases with asbestos-related diseases in the Netherlands. Ann Occup Hyg. 2003;47:485-92.
55. Al Jarad N, Strickland B, Bothamley G, Lock S, Logan-Sinclair R, Rudd RM. Diagnosis of asbestosis by a time expanded wave form analysis, auscultation and high resolution computed tomography: a comparative study. Thorax. 1993;48:347-53.
56. Kipen HM, Lilis R, Suzuki Y, Valciukas JA, Selikoff IJ. Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation. Br J Ind Med. 1987;44:96-100.
57. Chapman SJ, Cookson WO, Musk AW, Lee YC. Benign asbestos pleural diseases. Curr Opin Pulm Med. 2003;9:266-71.
58. Dumortier P, Thimpont J, De Maertelaer V, De Vuyst P. Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades. Eur Respir J. 2003;22:519-24.
59. Beckett W. Diagnosis of asbestosis. Primun non nocere. Chest. 1997;111:1427-8.
60. Begin R. Asbestos related diseases. En: Mapp CE, editor. Occupational Lung Disorders. European Respiratory Monograph; 1999. p. 158-77.
61. Hughes JM, Weill H. Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study. Br J Ind Med. 1991;48:229-33.
62. Karjalainen A, Pukkala E, Kauppinen T, Partanen T. Incidente of cancer among Finnish patients with asbestos-related pulmonary and pleural fibrosis. Cancer Causes Control. 1999;10:51-7.
63. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study. Am J Respir Crit Care Med. 2000;161:5-8.
64. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg. 2000;44:565-601.
65. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Torac Cardiovasc Surg. 1999;117:54-63.
66. Zellos LS, Sugarbaker DJ. Diffuse malignant mesothelioma of the pleural space and its management. Oncology. 2002;16:907-13.
67. Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med. 2002;43: 1144-9.
68. Gerbaudo VH, Britz-Cunningham S, Sugarbaker DJ, Treves ST. Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. Thorax. 2003; 58:1077-82.
69. Kelsey KT, Yano E, Liber HL, Little JB. The in vitro effects of fibrous erionite and crocidolite asbestos. Br J Cancer. 1986;54:107-14.
70. Hei TK, Piao CQ, He ZY, Vannais D, Waldren CA. Chrysotile fiber is a strong mutagen in in mammalian cells. Cancer Res. 1992;53:6305-9.
71. Jarvholm B, Larsson S, Hagberg S, Oiling S, Ryd W, Toren K. Quantitative importance of asbestos as a cause of lung cancer in a Swedish industrial city: a case-referent study. Eur Respir J. 1993; 6:1271-5.
72. Rosler JA, Woitowitz HJ, Lange HJ, Woitowitz RH, Ulm K, Rodelsperger K. Mortality rates in a female cohort following asbestos exposure in Germany. J Occup Med. 1994;36:889-93.
73. Browne K. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med. 1986;43:145-9.
74. Churg A. Asbestos, asbestosis and lung cancer. Mod Pathol. 1993; 6:509-11.
75. Weiss W. Asbestos-related pleural plaques and lung cancer. Chest. 1993;103:1854-9.
76. Jones RN, Hughes JM, Weill H. Asbestos exposure, asbestosis and asbestos-attributable lung cancer. Thorax. 1996;51 Suppl 2:9-15.
77. McDonald AD, Fry JS, Wooley AJ, McDonald JC. Dust exposure and mortality in an American chrysotile asbestos friction products plant. Br J Ind Med. 1984;41:151-7.
78. Roggli VL, Hammar SP, Pratt PC, Maddox JC, Legier J, Mark EJ, et al. Does asbestos or asbestosis cause carcinoma of the lung? Am J Ind Med. 1994;26:835-8.
79. Abraham JL. Asbestos inhalation, not asbestosis, causes lung cancer. Am J Ind Med. 1994;26:839-42.
80. Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scan J Work Environ Health. 1997;23:93-103.
81. Wilkinson P, Hansell DM, Janssens J, Rubens M, Rudd RM, Taylor AN, et al. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet. 1995;345:1074-8.
82. Steenland K, Thun M. Interaction between tobacco smoking and occupational exposures in the causation of lung cancer. J Occup Med. 1986;28:110-8.
83. Berry G, Newhouse ML, Turok M. Combined effects of asbestos exposure and smoking on mortality from lung cancer in factory workers. Lancet. 1972;2:476-8.
84. Woodworth CD, Mossman BT, Craighead JE. Squamous metaplasia of the respiratory tract. Possible pathogenic role in asbestos-associated bronchogenic carcinoma. Lab Invest. 1983;48:578-84.
85. Huilan Z, Zhiming W. Study of occupational lung cancer in asbestos factories in China. Br J Ind Med. 1993;50:1039-42.
86. Vaino H, Boffetta P. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health. 1994;20:235-42.
87. Kjuus H, Skjaerven R, Langard S. A case-referent study of lung cancer, occupational exposure and smoking. II: role of asbestos exposure. Scand J Work Environ Health. 1986;12:203-9.
88. Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am J Ind Med. 1996;29:474-90.
89. Karjalainen A, Anttila S, Vanhala E, Vainio H. Asbestos exposure and the risk of lung cancer in a general urban population. Scan J Work Environ Health. 1994;20:243-50.
90. Van Loon AJM, Kant IJ, Swaen GMH. Occupational exposure to carcinogens and risk of lung cancer: Results from the Netherlands cohort study. Occup Environ Med. 1997;54:817-24.
91. Magnani C, Leporati M. Mortality from lung cancer and population risk attributable to asbestos in an asbestos cement manufacturing town in Italy. Occup Environ Med. 1998;55:111-4.
92. Albin M, Magnani C, Krstev S, Rapiti E, Shefer I. Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect. 1999;107 Suppl 2:289-98.